Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Jirillo

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Recenti Progressi in Medicina|October 8, 2005
[Questionable methods in cancer therapy]Antonio Jirillo, Cristina Falci
Tumori|May 5, 2010
New rules on conflict of interest: what has to be done in Europe?Antonio Jirillo, Federica Vascon
Health Affairs (Project Hope)|October 7, 2011
Evaluations of new drugs after they reach the marketAntonio Jirillo, Marta P Trojniak
Lung Cancer (Amsterdam, Netherlands)|December 2, 2011
Does chemotherapy have a role after erlotinib treatment in NSCLC?Marta P Trojniak, Antonio Jirillo
Current Drug Targets|March 30, 2011
Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors and new therapeutic perspectives in non small cell lung cancerLaura Bonanno, Antonio Jirillo, Adolfo Favaretto
Recenti Progressi in Medicina|June 28, 2002
[Therapeutic decision in medical oncology]Antonio Jirillo, Micaela Stefani, Silvio Monfardini
Journal of Gastrointestinal Cancer|February 4, 2012
Green oncology: cultivating sustainability in medical oncologySalvatore Palazzo, Antonio Jirillo, Magdalena Mazurek
Immunopharmacology and Immunotoxicology|January 14, 2012
The impact of new cancer drugs in real practice oncology: a monoinstitutional experienceAntonio Jirillo, Silvia Imbevaro, Magdalena Mazurek
Tumori|October 12, 2012
The economic crisis and cancer chemotherapy: the role of the oncologistPaola Rescigno, Silvia Imbevaro, Antonio Jirillo
Tumori|April 27, 2005
Complete remission of poorly differentiated squamous liver carcinoma after systemic chemotherapy and surgery. A case reportGiorgia Boscolo, Antonio Jirillo, Pierpaolo Da Pian
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Recenti Progressi in Medicina|October 8, 2005
[Questionable methods in cancer therapy]Antonio Jirillo, Cristina Falci
Tumori|May 5, 2010
New rules on conflict of interest: what has to be done in Europe?Antonio Jirillo, Federica Vascon
Health Affairs (Project Hope)|October 7, 2011
Evaluations of new drugs after they reach the marketAntonio Jirillo, Marta P Trojniak
Lung Cancer (Amsterdam, Netherlands)|December 2, 2011
Does chemotherapy have a role after erlotinib treatment in NSCLC?Marta P Trojniak, Antonio Jirillo
Current Drug Targets|March 30, 2011
Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors and new therapeutic perspectives in non small cell lung cancerLaura Bonanno, Antonio Jirillo, Adolfo Favaretto
Recenti Progressi in Medicina|June 28, 2002
[Therapeutic decision in medical oncology]Antonio Jirillo, Micaela Stefani, Silvio Monfardini
Journal of Gastrointestinal Cancer|February 4, 2012
Green oncology: cultivating sustainability in medical oncologySalvatore Palazzo, Antonio Jirillo, Magdalena Mazurek
Immunopharmacology and Immunotoxicology|January 14, 2012
The impact of new cancer drugs in real practice oncology: a monoinstitutional experienceAntonio Jirillo, Silvia Imbevaro, Magdalena Mazurek
Tumori|October 12, 2012
The economic crisis and cancer chemotherapy: the role of the oncologistPaola Rescigno, Silvia Imbevaro, Antonio Jirillo
Tumori|April 27, 2005
Complete remission of poorly differentiated squamous liver carcinoma after systemic chemotherapy and surgery. A case reportGiorgia Boscolo, Antonio Jirillo, Pierpaolo Da Pian
Pageof 3